Spatial Genomics & Transcriptomics Industry Forecast to 2030: Personalized Medicine Drive Fuels Demand for Spatial Genomics & Transcriptomics, Revolutionizing Precision Healthcare
Thursday, August 31, 2023
DUBLIN, Aug. 23, 2023 /PRNewswire/ -- The "Spatial Genomics & Transcriptomics Industry Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
The global spatial genomics & transcriptomics market is projected to achieve a value of USD 574.3 million by 2030, with a compounded annual growth rate (CAGR) of 12.2% from 2023 to 2030. This growth trajectory is attributed to the increasing potential of spatial genomic analysis as a method for cancer detection and the emergence of advanced sequencing technology.
Market Dynamics
-- Drivers
-- Emerging Potential of Spatial Genomic Analysis as a Cancer
Diagnostic Tool
-- Advent of the Fourth Generation of Sequencing (In Situ Sequencing)
-- Emerging Players can Boost the Market Competitiveness
-- Restraints
-- Slow Implementation of Technology
-- Well-Established Workflows for Conventional Genomics &
Transcriptomics Analysis
Personalized Medicine Driving Demand
The transition towards personalized medicine, which aims to provide tailored healthcare based on individual characteristics, is a pivotal factor propelling the demand for spatial genomics and transcriptomics. These technologies offer an intricate understanding of genetic and molecular landscapes within patient tissues, enabling precise diagnosis, prognosis, and selection of treatment strategies. By identifying specific gene expression patterns linked to disease subtypes, clinicians can make informed decisions regarding personalized treatment approaches.
Advancements in Technology and Accessibility
Significant technological advancements have been witnessed in the spatial genomics & transcriptomics market. Companies are investing in research and development to enhance the accuracy, scalability, and affordability of platforms in this domain. The introduction of user-friendly and integrated solutions simplifies data analysis and interpretation, widening access to a broader user base.
For example, Vizgen introduced the world's first single-cell spatial genomics platform based on MERFISH technology, offering high resolution and efficiency for transcriptome profiling. These advancements are expanding market potential and attracting investments from academic and industrial sectors.
Market Highlights
-- The spatial transcriptomics technology segment dominated in 2022, driven
by its higher adoption rate compared to spatial genomic methods for
single-cell transcriptomic studies.
-- The consumables segment is projected to experience the fastest growth
during the forecast period, encompassing products essential for genome
mapping processes, from sample preparation to result derivation.
-- The translational research segment led in revenue share in 2022 due to
spatial omics technologies' potential benefits in providing
comprehensive analyses of disease states and physiological conditions
for research purposes.
-- The Asia Pacific region is expected to witness the fastest CAGR, fueled
by untapped opportunities in emerging economies like China and India.
Key Market Players
Prominent players in the spatial genomics & transcriptomics market include Natera Inc., 10x Genomics, Dovetail Genomics, Illumina, Inc., and S2 Genomics, Inc. These market players are contributing to advancements in the field, driving innovation, and expanding the market's growth potential.
Conclusion
The spatial genomics & transcriptomics market is on a trajectory of remarkable growth, driven by advancements in technology, the shift towards personalized medicine, and increasing demand for precise diagnosis and treatment strategies. As the field continues to evolve, it holds promise for revolutionizing our understanding of disease mechanisms and guiding more effective therapeutic interventions.
Key Attributes
Report Attribute Details
No. of Pages 180
Forecast Period 2022-2030
Estimated Market Value (USD) in 2022
$232.5 Million
Forecasted Market Value (USD) by 2030
$574.3 Million
Compound Annual Growth Rate 12.2 %
Regions Covered Global
Key Topics Covered
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Variables, Trends, & Scope
Chapter 4. Technology Business Analysis
Chapter 5. Product Business Analysis
Chapter 6. End-use Business Analysis
Chapter 7. Regional Business Analysis
Chapter 8. Competitive Landscape
Companies Mentioned
-- Natera, Inc.
-- 10x Genomics
-- Dovetail Genomics
-- Illumina, Inc.
-- S2 Genomics, Inc.
-- Nanostring Technologies, Inc.
-- Seven Bridges Genomics
-- Horizon Discovery Group PLC
-- Bio-Techne
For more information about this report visit https://www.researchandmarkets.com/r/bi0spr
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/spatial-genomics--transcriptomics-industry-forecast-to-2030-personalized-medicine-drive-fuels-demand-for-spatial-genomics--transcriptomics-revolutionizing-precision-healthcare-301907943.html
SOURCE Research and Markets
|
|
|
|
|
 |
Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026
|
|
Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026
|
|
DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026
|
|
Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026
|
|
Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026
|
|
Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026
|
|
Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026
|
|
Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026
|
|
Marketing Evolution Announces New Investment Led by Insight Partners to Power AI-Ready Marketing Data for the Agentic Era | Jan 22, 2026
|
|
Genpact Named a Leader in ISG Provider Lens(TM) 2025 for Insurance GCCs and Agentic AI Services | Jan 22, 2026
|
|
|
